# Baxter invests $100M to expand sterile fill/finish facility in Halle/Westfalen, Germany

Baxter International is investing approximately $100 million to expand its sterile fill/finish manufacturing facility in Halle/Westfalen, Germany, operated by BioPharma Solutions. The expansion will add a syringe filling line and additional vial capacity. Construction is expected to begin in 2022 and be completed in 2024.

- Type: Expansion
- Announced: 2021-11-11
- Where: Halle/Westfalen, Germany
- Value: $100.0M
- Starts operating: 2024
- Status: announced
- Products: sterile injectable pharmaceuticals, pre-filled syringes, lyophilized vials
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Baxter International](https://endata.com/companies/20761.md)

## Sources

- [baxter.com](https://www.baxter.com/news-insights/baxter-announces-100-million-investment-in-biopharma-solutions-halle-westfalen-germany-sterile-fill-finish-manufacturing-facility), 2021-11-11: "By making this investment, we are building on recent expansions to help ensure this facility can serve our partners at the highest level now and well into the future."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.